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Abstract: Serum biochemical changes were assessed to determine hepatic and renal function in 4 vervet monkeys experimentally
infected with Trypanosoma brucei gambiense, the causative agent of sleeping sickness in West and Central Africa. Parameters
examined included serum bilirubin, blood urea nitrogen (BUN), and cholesterol levels. Significant increases in the total bilirubin and
BUN levels occurred from the second week post-infection (PI) (P ≤ 0.05) and remained so until the monkeys died of infection, at
12 to 15 weeks PI. Serum cholesterol levels increased from the fourth week to the eighth week of infection. These changes
suggested early hepatic and renal pathology, and dysfunction in the monkeys, which were thought to be associated with the early
death of the primates. These observations were at variance with the typically mild and chronic nature of T. brucei gambiense in
humans. It was concluded that early hepatic and renal damage in trypanosomosis is an important obstacle to the success of
chemotherapy of sleeping sickness in humans, as the drugs themselves are thought to be hepatotoxic and nephrotoxic. Furthermore,
characterisation of atypically virulent T. brucei gambiense stains may be necessary in distinguishing such strains from T. brucei
rhodesiense and preventing the spread of Rhodesian sleeping sickness.
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Introduction
Human African trypanosomosis (HAT, sleeping
sickness) is still endemic in several parts of sub-Saharan
Africa, where it constitute a major health hazard in
endemic countries (1,2). The disease, though described as
one of the most neglected (3), has in the last decade
assumed greater global importance following resurgence
in endemic areas and reports of increasing number of
infections among tourists returning from tropical Africa
(4,5). Sleeping sickness arising from Trypanosoma brucei
gambiense constitutes a special problem going by the
debilitating nature of the Gambian disease, typically low
parasitaemia, which makes parasite detection difficult,
and the controversial roles of animal reservoir hosts
(6,7). The absence of suitable animal research models is
one of the most challenging constraints in the
understanding of the pathology arising from Gambian
sleeping sickness and distinguishing this from the
cytotoxic side effects of drugs during treatment (8).

This study was therefore aimed at assessing the
occurrence of hepatic and renal pathology (dysfunction)
arising from Gambian trypanosomosis using vervet
monkey as a model. This is with the view of enhancing
proper clinical management and chemotherapy of
sleeping sickness in humans.

Materials and Methods
Four male vervet monkeys (Cercopithecus aethiops)
having average body weight of 2.8 ± 0.8 kg were used
for the study. Two of the monkeys were randomly
selected and inoculated with the NITR/Abraka strain of T.
brucei gambiense isolated from Abraka, Nigeria, during
an outbreak of the disease in the area (9,10). The
remaining 2 monkeys were inoculated with the IL3250
strain similarly obtained from patients suffering form
6
sleeping sickness. A total of 2 x 10 parasites were used
to infect each of the monkeys intraperitoneally, while
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The direct bilirubin levels increased in the first week 6
weeks of infection, ranging from 145.9% by week 2 to
250.0% by week 6 PI. This was followed by a sharp drop
to pre-infection values by weeks 8 and 10. The serum
cholesterol levels of the monkeys also increased from the
fourth week of infection, the increase ranging from
28.12% in the fourth week to 34.33% in the eighth
week PI (Figure 2.). Increases in the BUN level of the T.
brucei gambiense-infected monkeys ranged from 29.7%
at week 2 PI to 187.9% and 166.2% by weeks 8 and 10,
respectively (Figure 2, P ≤ 0.05).

pre-infection data obtained for 4 weeks served as the
control for each animal.
Procedures for obtaining blood from the monkeys,
separation of serum, and handling were as previously
reported (11,12). Parameters determined included total
bilirubin, cholesterol, and blood urea nitrogen (BUN) as
previously described (13). The data obtained were
analysed using analysis of variance (ANOVA) to determine
the level of significance.

Results
After infection, both strains of T. brucei gambiense
behaved alike in the monkeys and were therefore treated
as one group. Changes in the serum total bilirubin, BUN,
and cholesterol levels were as summarised in the Table.

Discussion
The pattern of increase in total bilirubin level in the
monkeys following infection with T. brucei gambiense
supported earlier observations in experimental T. brucei
infection of dogs (14) and rabbits (15), and was due to
increases in direct bilirubin levels. The observations in the
vervet monkeys, however, differed from those reported
by Wellde et al. (16) in T. brucei rhodesiense-infected
sleeping sickness patients in the Lambwe valley of Kenya,
where serum bilirubin levels of infected people did not

The total bilirubin level of the T. brucei gambiense
infected primates increased above pre-infection values,
ranging form 188.0% to 268.1% increases in the
second and fourth week post-infection (PI),
respectively (Figure 1). Thereafter, the values declined
only slightly but remained above pre-infection values
until the tenth week (P ≤ 0.05).

Table. Summary of serum bilirubin, BUN, and cholesterol levels of vervet monkeys before and
after infection with T. brucei gambiense.
Pre-infection values
Bilirubin (Total) (mg/100 ml)
Bilirubin (Direct) (mg/100 ml)
Cholesterol (mg/dl)
Blood urea nitrogen (mg/dl)

0.2
0.1
121.3
29.8

±
±
±
±

Terminal values post-infection

0.0
0.1
8.2
2.4

0.5
0.1
125.5
75.5

±
±
±
±

0.0*
0.0
40.4
14.5*

Note: *: P ≤ 0.05
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Figure 1. Sequential changes in serum bilirubin levels of monkeys after
infection with T. b. gambiense.
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Figure 2. Sequential changes in serum cholesterol and BUN levels of
monkeys after infection with T. b. gambiense.
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differ statistically from those of the control population.
The increases in serum bilirubin levels in the primates
were suggestive of haemolytic anaemia in the monkeys
due to T. brucei gambiense infection, as earlier observed
by Anosa (17) or obstructive jaundice as previously
reported in T. brucei-infected rabbits (15).
Hypercholesteraemia demonstrated in the monkeys after
infection was higher than that observed in T. bruceiinfected
goats
(18)
and
rabbits
(15).
Hypercholesteraemia has been associated with hepatic
malfunction resulting from impairment of liver lipid
metabolism (18) in Africa trypanosomosis. In contrast,
hypocholesteraemia was the case in cattle experimentally
infected with human infective T. brucei rhodesiense (19)
and in goats infected with T. brucei (20).
Elevation in the BUN level in the T. brucei gambienseinfected monkeys was, however, in consonance with the
observation reported by Wellde et al. (16) in the Lambwe
Valley sleeping sickness patients in Kenya, and in T. brucei
infection of rabbits (15) and goats (18). Similar increases
were reported in acute caprine trypanosomosis arising
from infection with T. vivax (21). Elevated serum urea
has been associated with kidney diseases such as
glomerulonephritis, urinary tract obstruction, and
excessive protein catabolism associated with severe toxic
and febrile conditions (22). Fever and glomerulonephritis
are consistent features of African trypanosomosis (8) and
may have occurred in the vervet monkeys as a result of
the infection.
Significantly high serum bilirubin, cholesterol, and
urea levels in the T. brucei gambiense-infected monkeys
suggest that severe renal and hepatic pathology occurred
in the monkeys, which resulted in the malfunctioning of
these organs and early death of the monkeys 12 to 15
weeks PI.

This is at variance with the chronic nature of T. brucei
gambiense sleeping sickness in humans (23) and the
result of an earlier experimental infection in monkeys
(24). This suggests that the strains of T. brucei
gambiense used in this case were highly virulent and
atypical, and supports the reports of deaths associated
with the outbreak of sleeping sickness in Abraka focus
from where one of the strains was obtained (9,10).
In conclusion, the outcome of T. brucei gambiense
infection of vervet monkeys confirmed the prominent
role of haemolysis in the pathogenesis of anaemia in
African trypanosomosis. Similarly, an early haemolytic
crisis coupled with early hepatic and renal dysfunctions
associated with atypical T. brucei gambiense strains in
humans may play roles in the early death of patients
suffering from Gambian sleeping sickness. Furthermore,
early sequential assessment of renal and hepatic functions
of patients under treatment may be essential in
preventing death, as most of the trypanocides for both
early and late stage treatments themselves have cytotoxic
effects. Characterisation of atypically virulent T. brucei
gambiense strains is therefore necessary in distinguishing
these from T. brucei rhodesiense and preventing the
spread of Rhodesian sleeping sickness to other parts of
Africa.
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